Clinical Trials List
Protocol NumberIDE397-001
Active
2023-05-01 - 2025-12-31
Phase I
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Chung Lin Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Seu-Chun Yang Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Chin-Wei Kuo Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- 鍾秉軒 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
265~382 participants
